Weighing the Risks: Understanding the Side Effects of Ozempic and Wegovy for Weight Loss
Semaglutide, a drug commonly known as Ozempic, has been approved by the U.S. Food and Drug Administration to treat Type 2 diabetes since 2017.[0] However, during pre-approval studies, researchers noticed a remarkable side effect: people lost weight.[1] This led to the 2021 FDA approval of Wegovy, a higher dosage of semaglutide, for people with obesity […]
Continue reading